RESUMEN
OBJECTIVE: The authors investigated the functional status at ICU admission and at hospital discharge, and the impact of dysfunctions on survivors' lifespan. METHOD: Single-center retrospective cohort. The FSS (Functional Status Scale) was calculated at ICU admission and at hospital discharge. A new morbidity was defined as an increase in FSS ≥ 3. RESULTS: Among 1002 patients, there were 855 survivors. Of these, 194 (22.6%) had died by the end of the study; 45 (5.3%) had a new morbidity. Means in the motor domain at admission and discharge were 1.37 (SD: 0.82) and 1.53 (SD 0.95, pâ¯=â¯0.002). In the feeding domain, the means were 1.19 (SD 0.63) and 1.30 (SD 0.76), pâ¯=â¯0.002; global means were 6.93 (SD 2.45) and 7.2 (SD 2.94), pâ¯=â¯0.007. Acute respiratory failure requiring mechanical ventilation, the score PRISM IV, age < 5 years, and central nervous system tumors were independent predictors of new morbidity. New morbidity correlated with lower odds of survival after hospital discharge, considering all causes of death (pâ¯=â¯0.014), and was independently predictive of death (Cox hazard ratioâ¯=â¯1.98). In Weibull models, shortening in the life span of 14.2% (pâ¯=â¯0.014) was estimated as a new morbidity. CONCLUSIONS: New morbidities are related to age, disease severity at admission, and SNC tumors. New morbidities, in turn, correlate with lower probabilities of survival and shortening of the remaining life span. Physical rehabilitation interventions in this population of children may have the potential to provide an increase in lifespan.
Asunto(s)
Cuidados Críticos , Hospitalización , Niño , Humanos , Preescolar , Estudios Retrospectivos , Morbilidad , Alta del PacienteRESUMEN
BACKGROUND: The study aimed to describe the kinetics of various cytokines from day 1 to day 14 of the onset of fever in neutropenic children and to evaluate their performances as discriminators of sepsis in the first 24 hours of fever, the possible influence of filgrastim, and the functioning of the IL-23/IL-17 axis. METHODS: IL-1ß, TNF-α, IL-10, IL-12/23p40, IL-21, IL-6, IL-8, IL-17, G-CSF, and GM-CSF were measured in plasma on days 1, 2, 3, 5, and 14 from the onset of fever in 35 patients. RESULTS: Thirteen patients (37.1%) developed sepsis. In mixed models, IL-6, IL-8, IL-10, and G-CSF showed higher estimated means in septic patients (P < 0.005), and IL-12/23p40 and IL-17 in nonseptic patients (P < 0.05). On day 1, IL-6, IL-8, and IL-10 appeared upregulated in patients who received filgrastim. Only IL-6, IL-8, IL-10, and procalcitonin were useful as discriminators of sepsis. Associating the markers with each other or to a risk assessment model improved performance. CONCLUSIONS: Cytokines kinetics showed proinflammatory and anti-inflammatory responses similar to what is described in nonneutropenic patients. IL-8, IL-6, IL-10, and procalcitonin are useful as early biomarkers of sepsis. Filgrastim upregulates expression of these markers, and we observed deficiency in the IL-23-IL-17 axis accompanying sepsis.
Asunto(s)
Biomarcadores/sangre , Citocinas/biosíntesis , Filgrastim/farmacología , Interleucina-17/sangre , Interleucina-23/sangre , Sepsis/sangre , Factor Estimulante de Colonias de Granulocitos y Macrófagos , Humanos , Interleucina-10 , Interleucina-12/sangre , Interleucina-6/sangre , Interleucina-8/sangre , Cinética , Transducción de Señal/efectos de los fármacosRESUMEN
Antibiotic restriction can be useful in maintaining bacterial susceptibility. The objective of this study was verify if restriction of cefepime, the most frequently used cephalosporin in our neonatal intensive care unit (NICU), would ameliorate broad-spectrum susceptibility of Gram-negative isolates. Nine hundred and ninety-five premature and term newborns were divided into 3 cohorts, according to the prevalence of cefepime use in the unit: Group 1 (n=396) comprised patients admitted from January 2002 to December 2003, period in which cefepime was the most used broad-spectrum antibiotic. Patients in Group 2 (n=349) were admitted when piperacillin/tazobactam replaced cefepime (January to December 2004) and in Group 3 (n=250) when cefepime was reintroduced (January to September 2005). Meropenem was the alternative third-line antibiotic for all groups. Multiresistance was defined as resistance to 2 or more unrelated antibiotics, including necessarily a third or fourth generation cephalosporin, piperacillin/tazobactam or meropenem. Statistics involved Kruskal-Wallis, Mann-Whitney and logrank tests, Kaplan-Meier analysis. Groups were comparable in length of stay, time of mechanical ventilation, gestational age and birth weight. Ninety-eight Gram-negative isolates were analyzed. Patients were more likely to remain free of multiresistant isolates by Kaplan-Meier analysis in Group 2 when compared to Group 1 (p=0.017) and Group 3 (p=0.003). There was also a significant difference in meropenem resistance rates. Cefepime has a greater propensity to select multiresistant Gram-negative pathogens than piperacillin/tazobactam and should not be used extensively in neonatal intensive care.
Asunto(s)
Antibacterianos/administración & dosificación , Cefalosporinas/administración & dosificación , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Unidades de Cuidado Intensivo Neonatal , Cefepima , Estudios de Cohortes , Infecciones por Bacterias Gramnegativas/microbiología , Humanos , Recién Nacido , Recien Nacido Prematuro , Meropenem , Pruebas de Sensibilidad Microbiana , Ácido Penicilánico/administración & dosificación , Ácido Penicilánico/análogos & derivados , Piperacilina/administración & dosificación , Combinación Piperacilina y Tazobactam , Estudios Prospectivos , Tienamicinas/administración & dosificación , Factores de TiempoRESUMEN
OBJECTIVE: To introduce the notion of noninvasive mechanical ventilation as an alternative for invasive ventilation in children, describing advantages and disadvantages, indications, and the process of equipment installation. SOURCE OF DATA: Literature review through PubMed/Medline, using as source articles focusing on noninvasive ventilation in pediatric populations, as well as consensus statements and metanalyses concerning noninvasive ventilation in adults. SUMMARY OF THE FINDINGS: The main indication for noninvasive ventilation is respiratory failure due to hypercapnia. It is contra-indicated in the presence of hemodynamic instability. The advantages of noninvasive ventilation include: the equipment is easy to install; it is not invasive and involves less discomfort; there is a lower incidence of complications associated with the endotracheal tube; lower cost. The disadvantages are: gastric distention; transient hypoxemia; facial skin necrosis. The equipment required for noninvasive ventilation includes an interface (mask) and a respirator. The removal of noninvasive ventilation equipment is relatively simple, but chronic patients may require assistance in the home. CONCLUSIONS: Noninvasive ventilation is a less costly, efficient and simple to perform alternative in cases of respiratory failure without hemodynamic instability.